|
🦁
|
TREM-1 Mediates Inflammatory Injury and Cardiac Remodeling Following Myocardial Infarction.
17 auth.
A. Boufenzer,
J. Lemarié,
T. Simon,
M. Derive,
Y. Bouazza,
N. Tran,
F. Maskali,
Frédérique Groubatch,
P. Bonnin,
C. Bastien,
...
P. Bruneval,
P. Marie,
R. Cohen,
N. Danchin,
J. Silvestre,
H. Ait-Oufella,
S. Gibot
|
6 |
2015 |
6
🦁
|
|
🐜
|
Genetic and Pharmacological Inhibition of TREM-1 Limits the Development of Experimental Atherosclerosis.
17 auth.
J. Joffre,
Stephane Potteaux,
Lynda Zeboudj,
X. Loyer,
A. Boufenzer,
L. Laurans,
B. Esposito,
Marie Vandestienne,
S. D. de Jager,
Carole Hénique,
...
Ivana Zlatanova,
S. Taleb,
P. Bruneval,
A. Tedgui,
Z. Mallat,
S. Gibot,
H. Ait-Oufella
|
6 |
2016 |
6
🐜
|
|
🐜
|
TREM-1 multimerization is essential for its activation on monocytes and neutrophils
13 auth.
K. Carrasco,
A. Boufenzer,
L. Jolly,
Hélène Cordier,
Guanbo Wang,
A. Heck,
A. Cerwenka,
Emilie Vinolo,
A. Nazabal,
Alexandre Kriznik,
...
P. Launay,
S. Gibot,
M. Derive
|
6 |
2018 |
6
🐜
|
|
🐜
|
Effects of a TREM-Like Transcript 1–Derived Peptide During Hypodynamic Septic Shock in Pigs
10 auth.
M. Derive,
A. Boufenzer,
Y. Bouazza,
Frédérique Groubatch,
C. Alauzet,
D. Barraud,
...
A. Lozniewski,
P. Leroy,
N. Tran,
S. Gibot
|
5 |
2013 |
5
🐜
|
|
🦁
|
Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis
7 auth.
A. Boufenzer,
K. Carrasco,
L. Jolly,
Benjamin Brustolin,
Elisa Di-Pillo,
M. Derive,
...
S. Gibot
|
5 |
2021 |
5
🦁
|
|
🐬
|
Attenuation of Responses to Endotoxin by the Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor LR12 in Nonhuman Primate
M. Derive,
A. Boufenzer,
S. Gibot
|
5 |
2014 |
5
🐬
|
|
🐜
|
TREM-1 orchestrates Angiotensin II-induced monocyte trafficking and promotes experimental abdominal aortic aneurysm.
27 auth.
Marie Vandestienne,
Yujiao Zhang,
Icia Santos-Zas,
Rida Al-Rifai,
J. Joffre,
Andréas Giraud,
L. Laurans,
B. Esposito,
F. Pinet,
P. Bruneval,
J. Raffort,
F. Lareyre,
J. Vilar,
A. Boufenzer,
Lea Guyonnet,
...
C. Guerin,
E. Clauser,
J. Silvestre,
S. Lang,
L. Soulat-Dufour,
A. Tedgui,
Z. Mallat,
S. Taleb,
A. Boissonnas,
M. Derive,
G. Chinetti,
H. Ait-Oufella
|
5 |
2020 |
5
🐜
|
|
🐜
|
Bone marrow vs Wharton’s jelly mesenchymal stem cells in experimental sepsis: a comparative study
10 auth.
C. Laroye,
A. Boufenzer,
L. Jolly,
L. Cunat,
C. Alauzet,
J. Merlin,
...
C. Yguel,
D. Bensoussan,
L. Reppel,
S. Gibot
|
5 |
2019 |
5
🐜
|
|
🐜
|
sTREM-1 is a specific biomarker of TREM-1 pathway activation
11 auth.
L. Jolly,
K. Carrasco,
Margarita Salcedo-Magguilli,
J. Garaud,
S. Lambden,
T. van der Poll,
...
A. Mebazaa,
P. Laterre,
S. Gibot,
A. Boufenzer,
M. Derive
|
5 |
2021 |
5
🐜
|
